literature and neither found that such a condition was reported in this study.
In the present study, two of the three reported cases were treated with everolimus and an angiotensin converting enzyme inhibitor (lisinopril) while the third case was treated with tacrolimus but did not receive any angiotensin converting enzyme inhibitor. Both immune inhibitors alone or in combination with angiotensin converting enzyme inhibitors have earlier been reported to induce angioedema. Cases of drug-induced acquired angioedema do not have C1-esterase inhibitor deficiency, which is erroneously mentioned in the discussion section of the paper with a reference to Zvidi et al. [4] .
In conclusion, the paper describes and illustrates very nicely three patients with probable drug-induced abdominal angioedema, which seems to be a risk in heart transplant recipients treated with everolimus, tacrolimus and/or angiotensin converting enzyme inhibitors. The mechanism of the latter condition is not C1-esterase inhibitor deficiency but possibly a decreased degradation of bradykinin [5] .
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